Dana Ebbets-Reed

Title: Dana Ebbets-Reed: Innovator in Neoplastic Cell Growth Inhibition

Introduction

Dana Ebbets-Reed is a notable inventor based in Encinitas, California. He has made significant contributions to the field of biotechnology, particularly in the area of cancer research. His work focuses on methods and compositions that inhibit neoplastic cell growth, which is crucial for developing effective cancer treatments.

Latest Patents

Dana Ebbets-Reed holds a patent for "Methods and compositions for inhibiting neoplastic cell growth." This invention provides the genomic sequence of GSSP-2, along with GSSP-2 cDNAs and GSSP-2 polypeptides. The patent also includes polynucleotides featuring biallelic markers derived from the GSSP-2 gene and its flanking genomic regions. Furthermore, it outlines methods for genotyping nucleic acid molecules containing samples for one or more biallelic markers. The invention aims to detect statistical correlations between biallelic marker alleles and phenotypes, as well as between biallelic marker haplotypes and phenotypes. Additionally, it concerns methods and compositions for killing neoplastic cells or inhibiting their growth, focusing on compositions that induce cell proliferation arrest and apoptosis or necrosis for tumor treatment. Dana Ebbets-Reed has 1 patent to his name.

Career Highlights

Dana Ebbets-Reed is associated with Serono Genetics Institute S.A., where he continues to advance his research in cancer treatment. His innovative work has the potential to impact the lives of many individuals affected by cancer.

Collaborations

Dana has collaborated with notable coworkers, including Frances Yen-Potin and Blake Denison, who contribute to the research environment at Serono Genetics Institute S.A.

Conclusion

Dana Ebbets-Reed is a pioneering inventor whose work in inhibiting neoplastic cell growth represents a significant advancement in cancer research. His contributions are vital for the development of new therapeutic methods.